1. Home
  2. NSPR vs RGT Comparison

NSPR vs RGT Comparison

Compare NSPR & RGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NSPR
  • RGT
  • Stock Information
  • Founded
  • NSPR 2005
  • RGT 1986
  • Country
  • NSPR United States
  • RGT United States
  • Employees
  • NSPR N/A
  • RGT N/A
  • Industry
  • NSPR Medical/Dental Instruments
  • RGT Trusts Except Educational Religious and Charitable
  • Sector
  • NSPR Health Care
  • RGT Finance
  • Exchange
  • NSPR Nasdaq
  • RGT Nasdaq
  • Market Cap
  • NSPR 101.8M
  • RGT 83.4M
  • IPO Year
  • NSPR N/A
  • RGT N/A
  • Fundamental
  • Price
  • NSPR $2.41
  • RGT $13.00
  • Analyst Decision
  • NSPR Strong Buy
  • RGT
  • Analyst Count
  • NSPR 2
  • RGT 0
  • Target Price
  • NSPR $4.50
  • RGT N/A
  • AVG Volume (30 Days)
  • NSPR 78.7K
  • RGT 22.4K
  • Earning Date
  • NSPR 11-11-2025
  • RGT 01-01-0001
  • Dividend Yield
  • NSPR N/A
  • RGT 1.43%
  • EPS Growth
  • NSPR N/A
  • RGT N/A
  • EPS
  • NSPR N/A
  • RGT 0.92
  • Revenue
  • NSPR $7,066,000.00
  • RGT N/A
  • Revenue This Year
  • NSPR $7.48
  • RGT N/A
  • Revenue Next Year
  • NSPR $104.39
  • RGT N/A
  • P/E Ratio
  • NSPR N/A
  • RGT $11.42
  • Revenue Growth
  • NSPR 7.60
  • RGT N/A
  • 52 Week Low
  • NSPR $1.99
  • RGT $7.84
  • 52 Week High
  • NSPR $3.80
  • RGT $11.08
  • Technical
  • Relative Strength Index (RSI)
  • NSPR 47.99
  • RGT 70.94
  • Support Level
  • NSPR $2.37
  • RGT $12.53
  • Resistance Level
  • NSPR $2.45
  • RGT $13.24
  • Average True Range (ATR)
  • NSPR 0.07
  • RGT 0.14
  • MACD
  • NSPR -0.00
  • RGT 0.02
  • Stochastic Oscillator
  • NSPR 37.50
  • RGT 66.20

About NSPR InspireMD Inc.

InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.

About RGT Royce Global Value Trust Inc.

Royce Global Value Trust Inc is a diversified closed-end investment company. The fund spreads its investments across diversified sectors such as information technology, consumer discretionary, health care, materials, consumer staples, and energy. Geographically, it has presence in the region of the United Kingdom, Japan, the United States, Canada, France, Hong Kong, and Germany.

Share on Social Networks: